Alternatives to Compugen

Compugen is an Oncology tool: develops and commercializes novel drug candidates for oncology and immunology. Here are the 56 closest alternatives, compared on pricing, features and what real users say.

Compugen profile More Oncology alternatives

The 20 closest Oncology companies to Compugen

Welcome Networks
Not rated
Cloud computing, IT consulting, and managed IT services for businesses in Toronto, Vancouver, and Burnaby.
Visit site
O2 Networks
Not rated
Full-service IT support and consulting specializing in network design, implementation, and support.
Visit site
Moderna
2.0 out of 5 (1)
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Visit site
Immunai
Not rated
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Visit site
DeepCure
Not rated
AI-driven drug discovery platform accelerating breakthrough scientific research.
Visit site
Pixelgen Technologies
Not rated
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Visit site
Upstream Bio
Not rated
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Visit site
Infinimmune
Not rated
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Visit site
KaliVir Immunotherapeutics, Inc.
5.0 out of 5 (1)
Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Visit site
Janux Therapeutics
Not rated
A clinical-stage biopharmaceutical company developing novel immunotherapies.
Visit site
JaxBio
Not rated
AI-powered blood test for early cancer detection and subtyping.
Visit site
Gamida Cell
Not rated
Biotechnology company developing potentially curative cell therapies for cancer patients.
Visit site
Immix Biopharma, Inc.
Not rated
A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
Visit site
N-Power Medicine
Not rated
N-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.
Visit site
Nectin Therapeutics
Not rated
Biotech company developing next-generation immunotherapy agents to unlock the immune system.
Visit site
Trobix Bio
Not rated
Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.
Visit site
Genocure AI
Not rated
Genocure AI is developing AI-powered solutions for oncology drug discovery and development.
Visit site
Dren Bio
Not rated
Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.
Visit site
AY
Ayala Pharmaceuticals
Not rated
Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.
Visit site
Adaptive Biotechnologies
Not rated
Leveraging the adaptive immune system to diagnose and treat disease.
Visit site

Company	Rating	Visit
Welcome NetworksCloud computing, IT consulting, and managed IT services for businesses in Toronto, Vancouver, and Burnaby.	Not rated	Visit site
O2 NetworksFull-service IT support and consulting specializing in network design, implementation, and support.	Not rated	Visit site
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	2.0 out of 5 (1)	Visit site
ImmunaiMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.	Not rated	Visit site
DeepCureAI-driven drug discovery platform accelerating breakthrough scientific research.	Not rated	Visit site
Pixelgen TechnologiesA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.	Not rated	Visit site
Upstream BioClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.	Not rated	Visit site
InfinimmuneDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.	Not rated	Visit site
KaliVir Immunotherapeutics, Inc.Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.	5.0 out of 5 (1)	Visit site
Janux TherapeuticsA clinical-stage biopharmaceutical company developing novel immunotherapies.	Not rated	Visit site
JaxBioAI-powered blood test for early cancer detection and subtyping.	Not rated	Visit site
Gamida CellBiotechnology company developing potentially curative cell therapies for cancer patients.	Not rated	Visit site
Immix Biopharma, Inc.A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.	Not rated	Visit site
N-Power MedicineN-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.	Not rated	Visit site
Nectin TherapeuticsBiotech company developing next-generation immunotherapy agents to unlock the immune system.	Not rated	Visit site
Trobix BioPioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.	Not rated	Visit site
Genocure AIGenocure AI is developing AI-powered solutions for oncology drug discovery and development.	Not rated	Visit site
Dren BioBiopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.	Not rated	Visit site
AYAyala PharmaceuticalsClinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.	Not rated	Visit site
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the Compugen profile.

Sponsored rows are paid and labelled. Advertise on this page